Nr 546 nr546 2024 Study guides, Class notes & Summaries

Midterm Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 1-4 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Haloperidol, ziprasidone, and olanzapine Answer: increased risk of CVA, cognitive decline, and death in older adults with dementia and dementia related psychosis QUESTION aripiprazole black box warning Answer: medication with increased risk of suicide in...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Final Exam | Questions and Verified Answers| Latest Update 2023/ 2024 |Chamberlain Q: What antidepressant has the longest half life? Answer: fluoxetine Q: What antidepressant also treats social anxiety and insomnia Answer: paroxetine Q: What antidepressant treats anxious depression smokers require increased do...

Final Exam: NR546/ NR 546 (Latest Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review| Complete Guide with Questions and Verified Answers| 100% Correct- Chamberlain Q: SSRI MOA inhibit 5HT reuptake first line of treatment for depression Q: SSRI s/e Answer: 7 S's of SSRIs 1.Stomach l dysfunction onin syndrome difficulties dal thoughts s (weight) Q: serotonin s/e Answer: head, red, fed head = decreased anxiety, impul...

NR 546 Midterm Exam Chlorpromazine Thiazide & Pimozide Aripiprazole Correct! Clozapine & Olanzapine Question 2 2 / 2 pts The PMHNP has prescribed chlorpromazine hydrochloride (Thorazine) for a patient with psychosis, and the patient is to continue on the oral medication after discharge from the psychiatric unit. As part of educating the patient about the medication, the PMHNP should advise him or her to avoid: exercise. Correct! sun expos...

Final Exam: NR546/ NR 546 (NEW Update 2024/ 2025) Psychopharmacology for the Psychiatric-Mental Health Nurse Practitioner Review |Weeks 5-8 | Questions and Verified Answers| 100% Correct- Chamberlain QUESTION Tricyclic antidepressants (TCAs) Tricyclic antidepressants (TCAs) possess both SRI and NRI properties, but they also block other receptors, including α1-adrenergic, histamine-1, and muscarinic cholinergic receptors. TCAs are not used first-line because of the high incidence...